PLX MT Newswires 2 days ago Protalix Partners With Secarna to Jointly Develop Therapies for Rare Renal Indications
PLX PR Newswire 2 days ago Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
